With a focus on medical innovation and global R&D level as our target, we aim to cater to the emerging market demand in China by funding advances in Biotech, Drug R&D, Emerging Medical Service and Advanced Medical Devices. We primarily focus on early- to mid stage projects, but also consider other stages. Share Capital has launched three healthcare funds, which have invested in more than 80 projects.
Gusen Pharmaceutical is China's leading company devoted to the development and production of soft mist inhaler, and the only enterprise that is listed among the "national science and technology major projects" in soft mist inhaler, with high-end reagent technology as the cornerstone.
With a focus on drawing a lifestyle blueprint for the next generation of consumers, we aim to invest in innovative enterprises that reshape the value chain of traditional , or innovate the business model of segmented business. Share Capital has launched three consumer lifestyle focused innovation funds, which have invested in over 70 projects.
We follow the technological progress of China's leading scientific research teams, and mainly focus on AI, Big Data, Advanced Manufacturing, the New Generation of IT, and New Materials. We give priority to projects headquartered in the Greater Bay Area with Shenzhen as a center. Share Capital has launched a angel fund and a VC fund focused on hard&core technology which have invested in over 20 projects.
NavInfo (002405.SZ) is the pioneer in China's navigation map industry and develops "the brain of smart vehicles" through such core technologies as self-driving map, high-precision positioning, cloud service platform as well as automotive-grade chips applicable to ADAS and self-driving to empower smart mobility.
The world's enterprise-class smart service platform of data analysis and decision, committed to supporting the mid- and large-sized enterprises with highly complicated knowledge and management in their digital transformation by leveraging data analysis and digging and cognitive smart technology.